NVS Competitors & Alternatives
Compare Novartis AG ADR with similar stocks in the same industry
Drug Manufacturers - General
NVS
Main Stock$159.90
Tradestie Score
59
Market Cap
$254.99B
P/E Ratio
22.1
Revenue Growth
0.0%
Analyst Upside
-3.3%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$263.04
|
$448.07B | 29.4 | 65 | Compare |
|
ABBV
ABBVIE INC.
|
$261.07
|
$431.71B | 123.7 | 60 | Compare |
|
NVO
Novo-Nordisk A/S
|
$50.43
|
$262.92B | 11.7 | 58 | Compare |
|
AZN
AstraZeneca PLC
|
$195.15
|
$261.56B | 29.2 | 62 | Compare |
|
MRK
Merck & Co., Inc.
|
$129.56
|
$225.13B | 35.3 | 62 | Compare |
|
AMGN
Amgen Inc
|
$374.15
|
$160.70B | 25.1 | 69 | Compare |
|
PFE
Pfizer Inc.
|
$24.32
|
$154.70B | 18.2 | 60 | Compare |
|
GILD
Gilead Sciences Inc
|
$131.27
|
$137.92B | 17.2 | 67 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$43.16
|
$121.27B | 18.4 | 56 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$58.13
|
$96.54B | 15.8 | 63 | Compare |
More NVS Analysis
Data updated: Jul 03, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry